Page last updated: 2024-10-20

tryptamine and Chronic Disease

tryptamine has been researched along with Chronic Disease in 2 studies

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
D'Andrea, G2
Bussone, G2
Di Fiore, P1
Perini, F2
Gucciardi, A1
Bolner, A2
Aguggia, M2
Saracco, G1
Galloni, E2
Giordano, G1
Leon, A2
D'Amico, D1
Saracco, MG1
De Riva, V1
D'Arrigo, A1
Colavito, D1

Other Studies

2 other studies available for tryptamine and Chronic Disease

ArticleYear
Pathogenesis of chronic cluster headache and bouts: role of tryptamine, arginine metabolism and α
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2017, Volume: 38, Issue:Suppl 1

    Topics: Adrenergic alpha-1 Receptor Agonists; Adult; Aged; Aged, 80 and over; Arginine; Biomarkers; Chronic

2017
Tryptamine levels are low in plasma of chronic migraine and chronic tension-type headache.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2014, Volume: 35, Issue:12

    Topics: Adult; Aged; Chromatography, High Pressure Liquid; Chronic Disease; Female; Humans; Male; Middle Age

2014